![]() |
|
|

* Department of Environmental Physiology,
Center for Integrated Research in Science, Shimane University Faculty of Medicine, Izumo 693-8501, Japan and
** Department of Life Science and Biotechnology, Shimane University of Faculty of Life and Environmental Science, Matsue 690-8504, Japan
1To whom correspondence should be addressed. E-mail: michio1{at}med.shimane-u.ac.jp.
We investigated whether administration of docosahexaenoic acid (DHA), a major (n-3) fatty acid of the brain, ameliorates the impairment of learning ability in an animal model of Alzheimers disease (AD), rats infused with amyloid-ß (Aß) peptide (140) into the cerebral ventricle. Inbred 3rd generation male rats (20 wk old) fed a fish oildeficient diet were randomly divided into 4 groups: a vehicle group, an Aß peptide-infused group (Aß group), a DHA group, and an Aß + DHA group. A mini-osmotic pump filled with Aß peptide or vehicle was implanted in the rats, and they were tested for learning abilityrelated reference and working memory in an 8-arm radial maze. The rats were then orally fed DHA dissolved in 5% gum Arabic solution at 300 mg/(kg · d) (DHA and Aß + DHA groups) or vehicle alone (vehicle and Aß groups) and tested again for learning ability. DHA administered for 12 wk significantly reduced the increase in the number of reference and working memory errors in the Aß-infused rats, and increased both the cortico-hippocampal level of DHA and the molar ratio of DHA/arachidonic acid, suggesting an amelioration of the impaired spatial cognition learning ability. Furthermore, DHA suppressed the increases in the levels of lipid peroxide and reactive oxygen species in the cerebral cortex and the hippocampus of Aß-infused rats, suggesting that DHA increases antioxidative defenses. DHA is thus a possible therapeutic agent for ameliorating learning deficiencies due to Alzheimers disease.
KEY WORDS: docosahexaenoic acid therapeutic agent spatial working memory antioxidative defense Alzheimers disease
This article has been cited by other articles:
![]() |
W. S. Harris, D. Mozaffarian, M. Lefevre, C. D. Toner, J. Colombo, S. C. Cunnane, J. M. Holden, D. M. Klurfeld, M. C. Morris, and J. Whelan Towards Establishing Dietary Reference Intakes for Eicosapentaenoic and Docosahexaenoic Acids J. Nutr., April 1, 2009; 139(4): 804S - 819S. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-L. Chung, J.-J. Chen, and H.-M. Su Fish Oil Supplementation of Control and (n-3) Fatty Acid-Deficient Male Rats Enhances Reference and Working Memory Performance and Increases Brain Regional Docosahexaenoic Acid Levels J. Nutr., June 1, 2008; 138(6): 1165 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bousquet, M. Saint-Pierre, C. Julien, N. Salem Jr., F. Cicchetti, and F. Calon Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease FASEB J, April 1, 2008; 22(4): 1213 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-L. Ma, B. Teter, O. J. Ubeda, T. Morihara, D. Dhoot, M. D. Nyby, M. L. Tuck, S. A. Frautschy, and G. M. Cole Omega-3 Fatty Acid Docosahexaenoic Acid Increases SorLA/LR11, a Sorting Protein with Reduced Expression in Sporadic Alzheimer's Disease (AD): Relevance to AD Prevention J. Neurosci., December 26, 2007; 27(52): 14299 - 14307. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cherubini, C. Andres-Lacueva, A. Martin, F. Lauretani, A. D. Iorio, B. Bartali, A. Corsi, S. Bandinelli, M. P. Mattson, and L. Ferrucci Low Plasma N-3 Fatty Acids and Dementia in Older Persons: The InCHIANTI Study J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2007; 62(10): 1120 - 1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Green, H. Martinez-Coria, H. Khashwji, E. B. Hall, K. A. Yurko-Mauro, L. Ellis, and F. M. LaFerla Dietary Docosahexaenoic Acid and Docosapentaenoic Acid Ameliorate Amyloid-{beta} and Tau Pathology via a Mechanism Involving Presenilin 1 Levels J. Neurosci., April 18, 2007; 27(16): 4385 - 4395. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L Cheatham, J. Colombo, and S. E Carlson n-3 Fatty acids and cognitive and visual acuity development: methodologic and conceptual considerations Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1458 - 1466S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Coti Bertrand, J. R. O'Kusky, and S. M. Innis Maternal Dietary (n-3) Fatty Acid Deficiency Alters Neurogenesis in the Embryonic Rat Brain J. Nutr., June 1, 2006; 136(6): 1570 - 1575. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Haque, M. Hashimoto, M. Katakura, Y. Tanabe, Y. Hara, and O. Shido Long-Term Administration of Green Tea Catechins Improves Spatial Cognition Learning Ability in Rats J. Nutr., April 1, 2006; 136(4): 1043 - 1047. [Abstract] [Full Text] [PDF] |
||||